Sohm Inc.

SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery

SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development

SOHM, Inc. Announces Allowance of Another Divisional Patent in the Republic of South Korea

SOHM, Inc., Moving and Expanding Commercialization Capabilities with its New Vista, CA Facility

SOHM Achieves Breakthrough with ABBIE Gene Editing Platform, Advancing Strategic Partnership and Licensing Opportunities